Toll Free: 1-888-928-9744

CoLucid Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Published: May, 2015 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

CoLucid Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'CoLucid Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the CoLucid Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CoLucid Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of CoLucid Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of CoLucid Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the CoLucid Pharmaceuticals, Inc.'s pipeline products

Reason to Buy

- Evaluate CoLucid Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of CoLucid Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the CoLucid Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of CoLucid Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of CoLucid Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of CoLucid Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 CoLucid Pharmaceuticals, Inc. Snapshot 4 CoLucid Pharmaceuticals, Inc. Overview 4 Key Information 4 Key Facts 4 CoLucid Pharmaceuticals, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 CoLucid Pharmaceuticals, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 CoLucid Pharmaceuticals, Inc. - Pipeline Products Glance 9 CoLucid Pharmaceuticals, Inc. - Late Stage Pipeline Products 9 Phase III Products/Combination Treatment Modalities 9 CoLucid Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 CoLucid Pharmaceuticals, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 CoLucid Pharmaceuticals, Inc. - Drug Profiles 12 lasmiditan succinate 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 COL-204 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Conjugated Stigmine Program 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CoLucid Pharmaceuticals, Inc. - Pipeline Analysis 16 CoLucid Pharmaceuticals, Inc. - Pipeline Products by Target 16 CoLucid Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 17 CoLucid Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 18 CoLucid Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 19 CoLucid Pharmaceuticals, Inc. - Recent Pipeline Updates 20 CoLucid Pharmaceuticals, Inc. - Dormant Projects 22 CoLucid Pharmaceuticals, Inc. - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 24 Disclaimer 25
List of Tables
CoLucid Pharmaceuticals, Inc., Key Information 4 CoLucid Pharmaceuticals, Inc., Key Facts 4 CoLucid Pharmaceuticals, Inc. - Pipeline by Indication, 2015 6 CoLucid Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 7 CoLucid Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 8 CoLucid Pharmaceuticals, Inc. - Phase III, 2015 9 CoLucid Pharmaceuticals, Inc. - Phase II, 2015 10 CoLucid Pharmaceuticals, Inc. - Preclinical, 2015 11 CoLucid Pharmaceuticals, Inc. - Pipeline by Target, 2015 16 CoLucid Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 17 CoLucid Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 18 CoLucid Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 19 CoLucid Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 20 CoLucid Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 22



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify